An Open-Label, Multicenter Study to Assess the Efficacy of Switching to a Combination tablet Ezetimibe/Simvastatin 10mg/40mg, Compared to Doubling the Dose of Statin in Patients Hospitalized With a Coronary Event
- Registry ID
- EUCTR2004-002345-12
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Merck & Co. Inc.
- Start date
- 2005-01-26
- Last update
- 2026-08-16
Conditions
- hypercholesterolemia
- Hypercolesterolemia
Summary
Main objective : In patients taking a statin and admitted to a hospital for investigation of a coronary event, to evaluate the efficacy of switching to ezetimibe/simvastatin (10mg/40mg) on discharge compared to doucling the statin dose as added by the LDL-C values achieved after 12 weeks of treatment.
Locations
- , , Italy
- , , Austria
- , , Germany
- , , UK
View on source registry